“Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice” (2022) The Iraqi Journal of Veterinary Medicine, 46(2), pp. 53–65. doi:10.30539/ijvm.v46i2.1554.